News Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:15:28 2026-07-20 EDT			5-day change	1st Jan Change
1,441.60 ^INR	+1.61%		+0.15%	-4.61%

07-07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law	RE
06-24	Avendus Spark Upgrades Cipla to Buy from Add; Price Target is INR1,710	MT

All News

Mentions Relevance

06-24	Avendus Spark Upgrades Cipla to Buy from Add; Price Target is INR1,710	MT
06-16	Cipla Limited Appoints Shivam Puri as Chief Executive Officer of Its One India Business, Effective July 1, 2026	CI
06-11	Cipla's Goa, India Facility Receives VAI Status from US FDA	MT
05-14	Cipla Limited announces Annual dividend, payable on July 25, 2026	CI
05-14	Elara Securities Downgrades Cipla to Reduce from Accumulate; Price Target is INR1,349	MT
05-14	Elara Securities Downgrades Cipla to Sell from Neutral; Price Target is INR1,180	MT
05-14	JM Financial Upgrades Cipla to Buy from Add; Price Target is INR1,546	MT
05-14	Emkay Global Upgrades Cipla to Add from Reduce; Price Target is INR1,450	MT
05-14	Avendus Spark Upgrades Cipla to Add from Reduce; Price Target is INR1,455	MT
05-14	Nirmal Bang Downgrades Cipla to Hold from Buy; Price Target is INR1,404	MT
05-13	Cipla Limited, Q4 2026 Earnings Call, May 13, 2026
05-13	Cipla Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-13	Indian drugmaker Cipla misses Q4 profit view on weak US sales	RE
05-13	Cipla Q4 consol net profit 5.55 billion rupees	RE
05-13	Cipla Limited Appoints Sushrut Kulkarni as President & Global Chief - Integrated Product Development, Effective from May 18, 2026	CI
05-13	Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales	RE
05-08	Jefferies Adjusts Cipla's Price Target to INR1,120 From INR1,170, Keeps at Underperform	MT
05-05	Cipla Limited Launches Ciposcillo Advanced Oscillometer for Respiratory Diagnostics	CI
04-24	ICICI Securities Upgrades Cipla to Buy from Add; Price Target is INR1,550	MT
04-24	Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA	AQ
04-23	Cipla Limited Announces U.S. Fda Approval for First Ab-Rated Generic of Ventolin Hfa	CI
04-23	Cipla Arm Gets US FDA's Final Nod for Albuterol Sulfate Inhalation Aerosol; Shares Up 3%	MT
04-23	Cipla receives US FDA approval for first AB-rated generic of Ventolin HFA	RE
04-17	Cipla's manufacturing facility in Goa undergoes US FDA inspection	RE
04-02	Cipla expands U.S. respiratory portfolio with approval of nintedanib capsules (100mg & 150mg) for idiopathic pulmonary fibrosis	RE